Boehringer Ingelheim launches new swine vaccines in Europe

Boehringer Ingelheim has announced the launch of two new swine vaccines against porcine reproductive and respiratory syndrome (PRRS) in Europe.

The Ingelvac PRRSFLEX EU vaccine is indicated for piglets, while the ReproCyc PRRS EU is intended for breeding gilts and sows. Both will be introduced in most European countries during October.

Ingelvac PRRSFLEX EU reduces respiratory clinical signs and is the only piglet-specific PRRS vaccine on the European market. It can be used for the active immunisation of healthy pigs from 17 days of age onwards.

Meanwhile, ReproCyc PRRS EU allows breeding gilts and sows affected with the PRRS disease to be safely vaccinated in all stages of the reproductive cycle, resulting in a reduction of PRRS-induced reproductive disorders.

Dr Joachim Hasenmaier, responsible for the animal health and consumer healthcare corporate board divisions at Boehringer Ingelheim, said: "We are very confident that the simultaneous launch of our two new vaccines will significantly benefit swine farmers all over Europe."

The firm marked the 20th anniversary of the launch of its first product for PRRS last year.